ECSP003420A - USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES - Google Patents

USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES

Info

Publication number
ECSP003420A
ECSP003420A ECSP003420A ECSP003420A EC SP003420 A ECSP003420 A EC SP003420A EC SP003420 A ECSP003420 A EC SP003420A EC SP003420 A ECSP003420 A EC SP003420A
Authority
EC
Ecuador
Prior art keywords
combination therapies
cyp2d6
cyp2d6 inhibitors
inhibitors
drug
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Ronald Scott Obach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003420 priority Critical patent/ECSP003420A/en
Publication of ECSP003420A publication Critical patent/ECSP003420A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invención se refiere al uso de un inhibidor de CYP2D6 en combinación con un fármaco que tiene el metabolismo catalizado por CYP2D6, en la que el fármaco y el inhibidor de CYP2D6 no son el mismo compuesto; y las composiciones farmacéuticas para dicho uso.This invention relates to the use of a CYP2D6 inhibitor in combination with a drug having the CYP2D6 catalyzed metabolism, in which the drug and the CYP2D6 inhibitor are not the same compound; and pharmaceutical compositions for said use.

ECSP003420 2000-04-07 2000-04-07 USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES ECSP003420A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003420 ECSP003420A (en) 2000-04-07 2000-04-07 USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003420 ECSP003420A (en) 2000-04-07 2000-04-07 USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES

Publications (1)

Publication Number Publication Date
ECSP003420A true ECSP003420A (en) 2001-11-27

Family

ID=42041049

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003420 ECSP003420A (en) 2000-04-07 2000-04-07 USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES

Country Status (1)

Country Link
EC (1) ECSP003420A (en)

Similar Documents

Publication Publication Date Title
UY26092A1 (en) USE OF CYP2D6 INHIBITORS IN COMBINATION THERAPIES
ECSP055525A (en) TYROSINE KINASE INHIBITORS
AR050254A1 (en) INTERMEDIARIES AND PROCESSES TO PREPARE SUCH USEFUL INTERMEDIARIES IN THE MANUFACTURE OF PIRROLOTRIAZINES
CR9772A (en) ISOINDOL-IMIDA COMPOUNDS AND COMPOSITIONS THAT INCLUDE IT AND METHODS TO USE THE SAME
ECSP088543A (en) ANTI-OX40L ANTIBODIES AND METHODS THAT USE THEM
AR058433A1 (en) DERIVATIVE OF 1,1-DIOXIDE OF 1,4-BENZOTIAZEPIN, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THIS COMPOSITE AND ITS USE
CR8824A (en) DERIVATIVES OF 2-CARBAMIDA-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
UY26970A1 (en) COMBINED USE OF GABA ACETILCOLINESTERASE INHIBITORS AND AGONISTS, FOR THE TREATMENT OF COGNITIVE DISORDERS
CR10530A (en) ANTI-DLLA4 ANTIBODIES AND METHODS THAT USE THEM
AR058753A1 (en) USE OF NUTRITIONAL COMPOSITIONS WITH SPHINGOLIPID PHOSPHOLIPIDS AND CHOLESTEROL
ES2422556T3 (en) Viral hepatitis treatment
ECSP055671A (en) NEW ESPIROCONDENSED QUINAZOLINONES AND ITS USE AS PHOSPHODESTERESA INHIBITORS
ECSP044981A (en) OPHTHALMIC COMPOSITION THAT INCLUDES ASCOMYCIN
CL2007003540A1 (en) COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE SERINE PROTEASE OF HEPATITIS C; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C.
PA8575601A1 (en) PROCEDURE FOR PREPARATION, MEDICATIONS THAT INCLUDE THESE COMPOUNDS AND THEIR USE
GT200800107A (en) ORAL FORMULATIONS THAT INCLUDE TIGECICLINE
CR10280A (en) EFGL7 ANTIBODIES AND METHODS OF USE
GT200300231A (en) HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
UY27610A1 (en) COMBINATION OF PTM INHIBITORS OR INHIBITORS OF THE APOB SECRETION WITH FIBRATES FOR USE AS MEDICATIONS
DOP2000000022A (en) COMBINATION OF MTP INHIBITORS AND INHIBITORS OF HMG-COA REDUCTASA AND ITS USE IN MEDICINES.
AR030662A1 (en) BETA-TIO-ALFA-AMINO ACIDS, PROCEDURE FOR MANUFACTURING, MEDICINES CONTAINING THESE COMPOUNDS AND THE USE OF THIOAMINO ACIDS FOR THE PREPARATION OF MEDICINES
UY28148A1 (en) SCITALOPRAM BROMHYDRATE AND A METHOD FOR PREPARATION
CR9263A (en) USE OF SELECTIVE AGONISTS FOR THE STROGEN RECEIVER-ß FOR MUCOSITIS INDICATED BY RADIATION OR CHEMOTHERAPY AND FOR RADIATION-INDUCED CYSTITIS
GT199800081A (en) FARNESIL TRANSFERASA INHIBITORS COMBINED WITH HMG COA REDUCTASE INHIBITORS FOR DELCANCER TREATMENT.
AR043327A1 (en) USE OF QUINURENINE 3- HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES